Legal & General Group PLC Fulcrum Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 6,000 shares of FULC stock, worth $22,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,000
Holding current value
$22,620
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.98 - $9.31 $35,880 - $55,860
6,000 New
6,000 $37,000
Q1 2023

May 15, 2023
SELL
$2.83 - $13.99 $12,534 - $61,961
-4,429 Reduced 31.81%
9,496 $27,000
Q4 2022

Feb 14, 2023
BUY
$5.01 - $8.35 $5,340 - $8,901
1,066 Added 8.29%
13,925 $101,000
Q3 2022

Nov 14, 2022
SELL
$4.92 - $9.1 $21,943 - $40,586
-4,460 Reduced 25.75%
12,859 $104,000
Q2 2022

Aug 22, 2022
BUY
$4.2 - $24.0 $4,162 - $23,784
991 Added 6.07%
17,319 $85,000
Q1 2022

May 16, 2022
SELL
$9.96 - $23.65 $19,222 - $45,644
-1,930 Reduced 10.57%
16,328 $385,000
Q4 2021

Feb 14, 2022
BUY
$14.0 - $28.44 $225,806 - $458,708
16,129 Added 757.59%
18,258 $323,000
Q3 2021

Nov 15, 2021
BUY
$7.28 - $30.97 $2,649 - $11,273
364 Added 20.62%
2,129 $60,000
Q2 2021

Aug 12, 2021
SELL
$8.09 - $12.0 $1,156 - $1,716
-143 Reduced 7.49%
1,765 $18,000
Q1 2021

May 17, 2021
BUY
$10.94 - $15.32 $3,653 - $5,116
334 Added 21.22%
1,908 $22,000
Q3 2020

Nov 13, 2020
SELL
$7.22 - $20.7 $3,393 - $9,729
-470 Reduced 22.99%
1,574 $12,000
Q2 2020

Aug 14, 2020
BUY
$9.11 - $22.06 $956 - $2,316
105 Added 5.42%
2,044 $37,000
Q1 2020

May 14, 2020
BUY
$9.49 - $21.26 $8,645 - $19,367
911 Added 88.62%
1,939 $25,000
Q4 2019

Feb 13, 2020
BUY
$4.46 - $18.14 $677 - $2,757
152 Added 17.35%
1,028 $17,000
Q3 2019

Nov 13, 2019
BUY
$6.64 - $14.89 $5,816 - $13,043
876 New
876 $6,000

Others Institutions Holding FULC

# of Institutions
135
Shares Held
59.5M
Call Options Held
4.32M
Put Options Held
307K
View Full List

About Fulcrum Therapeutics, Inc.

FULC Quotes by TradingView
  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $196M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email